rs112122950
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_015141.4(GPD1L):c.520G>A(p.Glu174Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000517 in 1,608,816 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_015141.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000335 AC: 51AN: 152148Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000203 AC: 51AN: 251460Hom.: 0 AF XY: 0.000221 AC XY: 30AN XY: 135902
GnomAD4 exome AF: 0.000535 AC: 780AN: 1456668Hom.: 1 Cov.: 29 AF XY: 0.000494 AC XY: 358AN XY: 725112
GnomAD4 genome AF: 0.000335 AC: 51AN: 152148Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74328
ClinVar
Submissions by phenotype
not provided Uncertain:1Benign:1
- -
Reported in a male child with sudden unexplained death at 16 months of age, however, additional variants were also found and no segregation studies were reported (Sanchez et al., 2016); Also reported in one individual from a cohort of individuals not selected for cardiomyopathy, arrhythmia or family history of sudden cardiac death who underwent exome sequencing, although a follow-up cardiac evaluation was not described (Ng et al., 2013); In silico analysis supports that this missense variant does not alter protein structure/function; This variant is associated with the following publications: (PMID: 23861362, 27930701) -
Brugada syndrome 2 Uncertain:1
GPD1L NM_015141.3 exon 5 p.Glu174Lys (c.520G>A): This variant has not been reported in the literature and is present in 0.04% (53/129170) of European alleles in the Genome Aggregation Database (http://gnomad.broadinstitute.org/variant/3-32188128-G-A). This variant is present in ClinVar (Variation ID:180369). This variant amino acid Lysine (Lys) is present in multiple species including the parrot, scarlet macaw, and spiny softshell turtle, and it is not well conserved among evolutionarily distant species; this suggests that this variant may not impact the protein. Additional computational prediction tools do not suggest an impact. In summary, data on this variant is insufficient for disease classification. Therefore, the clinical significance of this variant is uncertain. -
Brugada syndrome Uncertain:1
This sequence change replaces glutamic acid, which is acidic and polar, with lysine, which is basic and polar, at codon 174 of the GPD1L protein (p.Glu174Lys). This variant is present in population databases (rs112122950, gnomAD 0.04%). This variant has not been reported in the literature in individuals affected with GPD1L-related conditions. ClinVar contains an entry for this variant (Variation ID: 180369). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GPD1L protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Sudden cardiac death Uncertain:1
- -
not specified Benign:1
Variant summary: GPD1L c.520G>A (p.Glu174Lys) results in a conservative amino acid change located in the N-terminal domain (IPR011128) of the encoded protein sequence. Four of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0002 in 251460 control chromosomes, predominantly at a frequency of 0.00039 within the Non-Finnish European subpopulation in the gnomAD database. The observed variant frequency within Non-Finnish European control individuals in the gnomAD database is approximately 39 fold of the estimated maximal expected allele frequency for a pathogenic variant in GPD1L causing Arrhythmia phenotype (1e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Non-Finnish European origin. c.520G>A has been reported in the literature as a VUS together with several other variants in at-least one 16-month old infant with sudden unexplained death (example, Sanchez 2016). The report does not provide unequivocal conclusions about association of the variant with Arrhythmia. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. Two ClinVar submitters (evaluation after 2014) cite the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as likely benign. -
Cardiovascular phenotype Benign:1
This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at